Skip to main content
Medical information Clinical review pending

Haematology Testing

Fibrinogen Degradation Products FDP Blood Test

The Fibrinogen Degradation Products (FDP) Blood Test helps diagnose blood clotting disorders by measuring FDP levels. Recommended for individuals with symptoms of abnormal bleeding or clotting.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
3 mL whole blood in a Blue Top (Sodium Citrate) tube. Mix thoroughly by inversion.
Results
Confirm with the laboratory before booking.
Preparation
Overnight fasting is preferred. A completed Coagulation Requisition Form (Form 15) is required.
Test priceKSh 2,293

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Fibrinogen Degradation Products FDP Blood Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Unexplained bruising or bleeding
  • ✓Swelling or pain in limbs
  • ✓Shortness of breath
  • ✓Suspected deep vein thrombosis (DVT)
  • ✓Suspected pulmonary embolism
  • ✓Monitoring coagulation disorders
  • ✓Family history of clotting disorders
02

In plain language

What this test helps you understand

This test aids in the diagnosis and monitoring of conditions involving abnormal blood clotting, such as disseminated intravascular coagulation (DIC), deep vein thrombosis (DVT), and pulmonary embolism. It helps assess the body's clotting and fibrinolytic processes.
The Fibrinogen Degradation Products (FDP) Blood Test is a diagnostic tool used to evaluate the presence of fibrin degradation products in the blood. This test is important for diagnosing various coagulation disorders, which can lead to serious health issues if not managed properly. Understanding your coagulation status is vital for effective management, especially for individuals at risk of bleeding or thrombotic events.

This test measures the levels of fibrinogen degradation products in the blood. Elevated levels can indicate abnormal clotting activity, potentially seen in conditions such as disseminated intravascular coagulation (DIC), deep vein thrombosis (DVT), or pulmonary embolism.

Taking this test can provide benefits like early detection of potential coagulation issues, guiding treatment decisions, monitoring anticoagulant therapy effectiveness, and providing peace of mind.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationOvernight fasting is preferred. A completed Coagulation Requisition Form (Form 15) is required.
Sample3 mL whole blood in a Blue Top (Sodium Citrate) tube. Mix thoroughly by inversion.
MethodologyConfirm with the laboratory before booking.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
Results should be interpreted alongside clinical findings and other relevant tests. Certain medications or conditions may affect FDP levels. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test measures the levels of fibrinogen degradation products in your blood, which are substances produced when blood clots break down.
It helps diagnose conditions related to abnormal blood clotting, such as DIC, DVT, or pulmonary embolism, and guides treatment decisions.
Overnight fasting is preferred for optimal results. Please check with the laboratory for specific instructions.
The sample is collected in a specific blue-top tube. The laboratory will provide detailed instructions on collection and transport.
Elevated levels can indicate increased clot breakdown, which may be associated with various conditions. Your doctor will interpret the results.
Turnaround time varies. Please contact the laboratory for specific information regarding this test.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp